Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Strand

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Brain : a Journal of Neurology|October 2, 2004
Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsyD C Paviour, A J Lees, K A Josephs, et al.
Neurology|February 27, 2008
Neuropathology of primary adult-onset dystoniaJ L Holton, S A Schneider, T Ganesharajah, et al.
Brain : a Journal of Neurology|April 19, 2002
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsyH R Morris, G Gibb, R Katzenschlager, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemiaG C Palmer, E C Cregan, A R Borrelli, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1989
Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profilesG C Palmer, M J Ordy, R D Simmons, et al.
Journal of Clinical Pharmacology|February 12, 2010
Clinical pharmacokinetics of pregabalin in healthy volunteersHoward N Bockbrader, Louis L Radulovic, Edward L Posvar, et al.
Neuropathology and Applied Neurobiology|June 6, 2003
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodiesR de Silva, T Lashley, G Gibb, et al.
Neuroimage. Clinical|December 17, 2016
9.4 T MR microscopy of the substantia nigra with pathological validation in controls and diseaseL A Massey, M A Miranda, O Al-Helli, et al.
Neuroimage|November 1, 2011
High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validationL A Massey, M A Miranda, L Zrinzo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 20, 2012
Animal models of neurologic disorders: a nonhuman primate model of spinal cord injuryYvette S Nout, Ephron S Rosenzweig, John H Brock, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Brain : a Journal of Neurology|October 2, 2004
Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsyD C Paviour, A J Lees, K A Josephs, et al.
Neurology|February 27, 2008
Neuropathology of primary adult-onset dystoniaJ L Holton, S A Schneider, T Ganesharajah, et al.
Brain : a Journal of Neurology|April 19, 2002
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsyH R Morris, G Gibb, R Katzenschlager, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemiaG C Palmer, E C Cregan, A R Borrelli, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1989
Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profilesG C Palmer, M J Ordy, R D Simmons, et al.
Journal of Clinical Pharmacology|February 12, 2010
Clinical pharmacokinetics of pregabalin in healthy volunteersHoward N Bockbrader, Louis L Radulovic, Edward L Posvar, et al.
Neuropathology and Applied Neurobiology|June 6, 2003
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodiesR de Silva, T Lashley, G Gibb, et al.
Neuroimage. Clinical|December 17, 2016
9.4 T MR microscopy of the substantia nigra with pathological validation in controls and diseaseL A Massey, M A Miranda, O Al-Helli, et al.
Neuroimage|November 1, 2011
High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validationL A Massey, M A Miranda, L Zrinzo, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 20, 2012
Animal models of neurologic disorders: a nonhuman primate model of spinal cord injuryYvette S Nout, Ephron S Rosenzweig, John H Brock, et al.
Pageof 8